Press Release Archives - CorVista Health

21 May The CorVista® Analysis provides a supervised machine-learned algorithm to IDENTIFY PH patients with New Onset Symptoms

Posted at 13:55h in Press Release by A4L Admin

0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text] IDENTIFY PH presented at ATS Washington DC—May 21, 2023—CorVista Health, Inc, a leading digital health company dedicated to improving cardiovascular disease diagnosis, announces the presentation of a machine-learned algorithm to IDENTIFY PH at the American Thoracic Society (ATS) (ML)...

17 Nov The CorVista® Analysis provides a robust prediction for elevated left ventricular end diastolic pressure at the point of-care

Posted at 13:01h in Press Release by A4L Admin

0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text] IDENTIFY Study Results Published in PLOS ONE Washington DC—November 17, 2022—CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces the publishing of the IDENTIFY Study in PLOS ONE, the multicenter validation...

26 Oct CorVista Health receives Breakthrough Device Designation for The CorVista® System

Posted at 16:15h in Press Release by A4L Admin

0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]Washington DC—October 25, 2022—CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the CorVista System as a first...

08 Jun CorVista Health Announces Drs. Vallerie V. McLaughlin and Mark G. Rabbat Join Medical Advisory Board

Posted at 16:00h in Press Release by A4L Admin

0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] Washington, DC, June 8, 2022 — CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the expansion of their Medical Advisory Board with the appointment of Drs. Vallerie V. McLaughlin and Mark G. Rabbat. ...

16 Feb Charles R. Bridges, M.D., Sc.D., Elected to the National Academy of Engineering Membership

Posted at 16:00h in Press Release by A4L Admin

0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text] Also Appointed to Board of Directors of The Forsyth Institute Washington, DC, February 16, 2022 — CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the election of Dr. Charles Bridges to the...